Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefuroxime vs Ceftriaxone for SSI Prophylaxis in Neurosurgery
NCT05398081Phase 2Completed
- Start
- Dec 2021
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of cefuroxime in surgical site infection (SSI) (2 arms). Primary endpoints: Surgical site infection at 6 weeks and Types and number of organism(s) causing surgical site infection at 6 weeks. Started Dec 2021; status: completed.
02
Drugs
cefuroxime
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT05398081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05398081.